HCA Stock Up 11% after 10-Day Win Streak
HCA Healthcare (HCA) stock hit day 10 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 11% return. The company has gained about $10 Bil in value over the last 10 days, with its current market capitalization at about $93 Bil. The stock remains 31.7% above its value at the end of 2024. This compares with year-to-date returns of 10% for the S&P 500.
HCA provides comprehensive healthcare services across 182 U.S. hospitals, including general, psychiatric, and rehabilitation care, specializing in inpatient, intensive, cardiac, diagnostic, and emergency services. After this rally, is HCA still a buy – or is it time to lock in gains? Deep dive with Buy or Sell HCA.
Comparing HCA Stock Returns With The S&P 500
The following table summarizes the return for HCA stock vs. the S&P 500 index over different periods, including the current streak:
- What Could Rocket Alphabet Stock to New Heights
- The Hidden Dangers Facing Micron Technology Stock
- Cash Machine Trading Cheap – Docusign Stock Set to Run?
- Micron Technology Stock On A Winning Streak: Time To Get In Or Book Profits?
- Is Microsoft Stock Poised for a Rally?
- With Strong Cash Flow, Constellation Brands Stock Poised to Rise?
| Return Period | HCA | S&P 500 |
|---|---|---|
| 1D | 0.8% | 0.0% |
| 10D (Current Streak) | 11.2% | 2.0% |
| 1M (21D) | 8.6% | 3.3% |
| 3M (63D) | 7.3% | 9.8% |
| YTD 2025 | 31.7% | 10.0% |
| 2024 | 11.8% | 23.3% |
| 2023 | 13.8% | 24.2% |
| 2022 | -5.6% | -19.4% |
What is the point? Momentum often precedes conviction. A multi-day win streak can signal growing investor confidence or spark follow-on buying. Tracking such trends can help you ride the strength, or prepare for a well-timed entry if momentum fades. However, big gains can follow sharp reversals – but how has HCA behaved after prior drops? See HCA Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 87 S&P constituents with 3 days or more of consecutive gains and 15 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 61 | 9 |
| 4D | 6 | 1 |
| 5D | 11 | 4 |
| 6D | 7 | 1 |
| 7D or more | 2 | 0 |
| Total >=3 D | 87 | 15 |
Key Financials for HCA Healthcare (HCA)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $65.0 Bil | $70.6 Bil |
| Operating Income | $9.6 Bil | $10.5 Bil |
| Net Income | $5.2 Bil | $5.8 Bil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ1 | 2025 FQ2 |
|---|---|---|
| Revenues | $18.3 Bil | $18.6 Bil |
| Operating Income | $2.9 Bil | $3.0 Bil |
| Net Income | $1.6 Bil | $1.7 Bil |
While HCA stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.